静止性皮肤炎:病理生理学,当前的治疗模式,以及使用黄酸二胺的使用
Nardin Awad1, John D Hetzel1, Vishnu Bhupalam1
1All authors are with the Center for Clinical and Cosmetic Research in Aventura, Florida.
The Journal of clinical and aesthetic dermatology
|February 1, 2024
概括
迪奥斯是一种类黄类化合物,通过改善静脉症状和治愈而有效治疗停滞性皮肤炎. 这种治疗显示出良好的安全性和潜在的其他皮肤疾病.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 血管医学 血管医学
背景情况:
- 停滞性皮肤炎 (SD) 是一种慢性炎症性皮肤疾病.
- 目前对SD的治疗方法有局限性.
- 像迪奥斯这样的黄类药物正在研究SD的治疗潜力.
研究的目的:
- 评估黄类药物,特别是迪奥斯在治疗停滞性皮肤炎中的作用.
- 审查迪奥斯对SD的病理生理学,治疗,作用机制和临床疗效.
主要方法:
- 在PubMed.com上进行了系统的文献搜索.
- 搜索术语包括"Diosmin"",MPFF"",微化纯化黄类分离物"",黄类","静脉性皮肤炎"",静脉"和"脂质皮质硬化".
- 重点是随机对照试验,比较口服黄类药物与安慰剂或标准治疗.
主要成果:
- 迪奥斯显著改善静止变化和愈频率,并减少愈合时间.
- 它有效地减少组织,并通过减少静脉症状来改善患者的生活质量.
- 迪奥斯明表现出有利的安全性,副作用最小,轻微,与安慰剂相比.
结论:
- 证据支持迪奥斯在治疗停滞性皮肤炎的治疗效果.
- 这些发现表明,在具有类似病理的条件下,黄类药物可能具有更广泛的皮肤学应用.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
175
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
175
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
298
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
298
Skin Diseases and Disorders
3.9K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.9K
COPD: Pathogenesis and Clinical Features
274
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
274


